Medinotec Inc.
MDNC
$5.00
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -28.18% | -21.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -28.18% | -21.61% | |||
| Cost of Revenue | -18.75% | -3.50% | |||
| Gross Profit | -36.51% | -32.77% | |||
| SG&A Expenses | 33.06% | -44.47% | |||
| Depreciation & Amortization | 655.84% | 2.67% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.15% | -26.72% | |||
| Operating Income | -147.80% | 4.56% | |||
| Income Before Tax | -150.32% | 1.10% | |||
| Income Tax Expenses | -246.37% | -26.80% | |||
| Earnings from Continuing Operations | -117.18% | 16.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -117.18% | 16.39% | |||
| EBIT | -147.80% | 4.56% | |||
| EBITDA | -136.76% | 4.53% | |||
| EPS Basic | -123.00% | 0.00% | |||
| Normalized Basic EPS | -167.86% | -13.10% | |||
| EPS Diluted | -123.00% | 0.00% | |||
| Normalized Diluted EPS | -167.86% | -13.10% | |||
| Average Basic Shares Outstanding | -25.60% | 16.40% | |||
| Average Diluted Shares Outstanding | -25.60% | 16.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||